Life insurance prospectuses
Below you'll find the most recent fund fact sheets, prospectuses, shareholder reports and other key fund documents for RiverSource Life Insurance. All documents are PDF files and require the free software Adobe Reader®.
Please read any prospectus carefully before you invest or send money.
Request a complimentary initial consultation with a financial advisor near you.
Life Insurance Prospectuses
Insurance products currently sold:
- RiverSource Variable Universal Life IV and RiverSource Variable Universal Life IV - Estate Series
- RiverSource Succession Select® Variable Life Insurance
- Variable Universal Life IV and Variable Universal Life IV - Estate Series - New York
- Succession Select Variable Life Insurance - New York
Insurance products no longer sold:
- RiverSource Variable Universal Life Insurance
- RiverSource Variable Universal Life III
- Variable Universal Life - New York
- Variable Universal Life III - New York
You should consider the investment objectives, risks, charges and expenses of the variable product carefully before investing. For a free copy of the prospectus, which contains this and other information about variable life insurance, call (800) 437-4332. Read the prospectus carefully before you invest.
Variable life insurance is a complex vehicle. Before you invest, be sure to ask your financial professional about the variable life insurance policy's features, benefits, risk and fees, and whether the variable life insurance is appropriate for you, based upon your financial situation and objectives.
RiverSource Distributors, Inc. (Distributor), Member FINRA. Insurance and annuity products are issued by RiverSource Life Insurance Company and in New York, by RiverSource Life Insurance Co. of New York, Albany, New York. These companies are affiliated with Ameriprise Financial Services, Inc. Only RiverSource Life Insurance Co. of New York is authorized to sell insurance and annuities in New York.
The initial consultation provides an overview of financial planning concepts. You will not receive written analysis and/or recommendations.